e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
T-cell interferon-γ release assays: can we do better?
Lalvani A., Millington K. A.
Source:
Eur Respir J 2008; 32: 1428-1430
Journal Issue:
December
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lalvani A., Millington K. A.. T-cell interferon-γ release assays: can we do better?. Eur Respir J 2008; 32: 1428-1430
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?
Source: Eur Respir J 2009; 33: 1250-1253
Year: 2009
Interferon-γ release assay tests to rule out active tuberculosis
Source: Eur Respir J 2007; 30: 183-184
Year: 2007
Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients
Source: Eur Respir J 2010; 35: 1179-1182
Year: 2010
Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
T
reg
cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Combination of interferon-γ and non-interferon-γ cytokines in tuberculosis specific cytokine release assays (TUCRA)
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010
Interferon-gamma release assays in tuberculosis contacts: is there a window period?
Source: Eur Respir J 2011; 37: 215-217
Year: 2011
Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)?
Source: International Congress 2018 – Important changes in the management of tuberculosis
Year: 2018
Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011
Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells
Source: Eur Respir J 2004; 24: 360-366
Year: 2004
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy
Source: Eur Respir J 2007; 30: 1173-1179
Year: 2007
Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Sarcoidosis following specific immunotherapy - more than just coincidence!
Source: Eur Respir J 2005; 26: Suppl. 49, 33s
Year: 2005
HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells
Source: Eur Respir J 2002; 20: 1174-1178
Year: 2002
Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins
Source: Eur Respir J 2010; 36: 215-216
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept